Ilanah J. Pruis

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Molecular imaging in pituitary neuroendocrine tumors: a narrative review of advances, challenges, and future perspectives.

Molecular imaging in pituitary neuroendocrine tumors: a narrative review of advances, challenges, and future perspectives.

Journal: European journal of endocrinology

Published: February 20, 2026

Clinical evaluation of [18F]fluoro-2-deoxy-d-glucose positron emission tomography-magnetic resonance imaging ([18F]FDG PET-MRI) and [18F]FDG PET-computed tomography ([18F]FDG PET-CT) for lymph node assessment in head and neck squamous cell carcinoma.

Clinical evaluation of [18F]fluoro-2-deoxy-d-glucose positron emission tomography-magnetic resonance imaging ([18F]FDG PET-MRI) and [18F]FDG PET-computed tomography ([18F]FDG PET-CT) for lymph node assessment in head and neck squamous cell carcinoma.

Journal: Clinical radiology

Published: February 26, 2025

PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study.

PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 17, 2025

[18F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.

[18F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 12, 2023

Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.

Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.

Journal: EBioMedicine

Published: August 24, 2023

Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners.

Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners.

Journal: Scientific reports

Published: May 17, 2023

PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.

PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 16, 2023

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances.

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances.

Journal: Diagnostics (Basel, Switzerland)

Published: June 20, 2022

Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters.

Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters.

Journal: Neuro-oncology advances

Published: March 18, 2022

Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis.

Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis.

Journal: Frontiers in neurology

Published: June 23, 2020

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.

Journal: International journal of molecular sciences

Published: January 06, 2020

High amyloid burden is associated with fewer specific words during spontaneous speech in individuals with subjective cognitive decline.

High amyloid burden is associated with fewer specific words during spontaneous speech in individuals with subjective cognitive decline.

Journal: Neuropsychologia

Published: August 30, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026